Parkinsonism and bipolar affective disorder.
Northcott
C
C
Lunn
V
V
Yatham
L N
LN
D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage; D001714:Bipolar Disorder / Q000188:drug therapy / Q000503:physiopathology*; D002230:Carbidopa / Q000008:administration & dosage; D002998:Clonazepam / Q000008:administration & dosage; D004298:Dopamine / Q000502:physiology; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D016651:Lithium Carbonate / Q000008:administration & dosage; D008297:Male; D010302:Parkinson Disease, Secondary / Q000188:drug therapy / Q000503:physiopathology*
D000978:Antiparkinson Agents; D004338:Drug Combinations; C009265:carbidopa, levodopa drug combination; D016651:Lithium Carbonate; D007980:Levodopa; D002998:Clonazepam; D002230:Carbidopa; D004298:Dopamine